Project Grant R03DK147543
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Florida $754,682 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) beginning May 1, 2026, and continuing through April 30, 2030. This Project Grant funds research investigating beta cell impairment in Type 1 Diabetes (T1D) through analysis of glucose metabolism in human pancreatic tissue samples. The research...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Florida a Project Grant of $1,599,136 on August 18, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a precision medicine clinical trial addressing Type 1 Diabetes (T1D) treatment. The research will evaluate anti-thymocyte globulin (ATG), a T cell-specific immune therapy, with and without verapamil (a...
- Federal Grant Award Summary Florida State University received a $2.78M Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2029. The award supports fundamental research to elucidate the molecular mechanisms by which pancreatic beta cells transition from adaptive responses to maladaptive dysfunction under...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $455,491 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded August 1, 2025, with a completion date of May 31, 2030. This research project focuses on elucidating the regulatory mechanisms of T follicular helper (TFH) cells and regulatory T follicular helper (TFR)...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Virginia a $1.44 million Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period May 1, 2026 through April 30, 2029. This ancillary research project will utilize data and peripheral blood mononuclear cell (PBMC) samples from the Environmental Determinants of Diabetes in the Young (TEDDY) longitudinal...
- Federal Grant Award Summary The University of Minnesota, through its Office of Sponsored Projects Administration, received a $4.51 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective September 5, 2025, through August 31, 2028, funds research to develop engineered regulatory T cells (Tregs) as a therapeutic approach for Type 1...
- Federal Grant Award Summary The University of Colorado-Denver received a $797,416 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026 through March 31, 2029. The award funds research investigating the immunogenetic mechanisms underlying Type 1 Diabetes (T1D) etiology and pathogenesis, with a focus on how genetic variability in natural...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Scripps Research Institute a $801,662 Project Grant effective August 15, 2025, through June 30, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project investigates the initiation of anti-islet autoimmunity in Type 1 Diabetes (T1D), a CD4 T cell-mediated autoimmune disease, with particular focus on understanding the role...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $795,806 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on May 20, 2026, with completion targeted for April 30, 2031. This research initiative investigates the molecular mechanisms by which glucocorticoid receptors (GRs) regulate skeletal...
- Federal Grant Award Summary The University of Texas Health Science Center at Houston received a $149,264 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 5, 2026, with a completion date of December 31, 2028. This award funds basic biomedical research investigating the role of GA-binding protein (GABP) in pancreatic beta cell survival...
The University of Florida received a $153,500 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026, through April 30, 2028. The award supports research investigating thymic output in the context of genetics, environmental exposures, and progression to type 1 diabetes (T1D). The research addresses critical gaps in understanding how thymic function is impacted during the early stages of T1D development, with particular focus on the interplay between genetic risk factors and environmental stimuli in initiating autoimmune responses that lead to pancreatic beta cell loss. The research project will deliver scientific knowledge and analysis examining how the thymus responds to environmental factors such as stress, nutritional changes, and viral infections during T1D progression. By analyzing thymic function through immunological assessment methods, the project aims to advance understanding of early initiating events in T1D pathogenesis beyond current peripheral T cell phenotype analyses. This research directly supports NIDDK's programmatic objectives to improve prevention, diagnosis, and treatment of diabetes through fundamental and clinical biomedical research addressing disease mechanisms and etiology.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $153.5k | 4/29/26 |